A randomized, controlled exposure study in adult smokers of full flavor Marlboro cigarettes switching to Marlboro Lights or Marlboro Ultra Lights cigarettes

Regulatory Toxicology and Pharmacology

Volumn 51, Issue 3, 2008, Pages 295-305

  Mendes, Paul ^a   Kapur, Sunil ^a   Wang, Jingzhu ^a   Feng, Shixia ^a   Roethig, Hans ^a  

^a Philip Morris USA Research Center   (United States)

Author keywords

Biomarkers of exposure; CO; Low tar cigarettes; Nicotine; Smoking topography

Indexed keywords

4 (METHYLNITROSAMINO) 1 (3 PYRIDYL) 1 BUTANONE; ACROLEIN; BENZENE; BIOLOGICAL MARKER; CARBON MONOXIDE; CIGARETTE SMOKE; MUTAGENIC AGENT; NICOTINE; PYRENE; TAR;

ADULT; ARTICLE; CHEMICAL COMPOSITION; CIGARETTE SMOKING; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; PRIORITY JOURNAL; RISK ASSESSMENT; TOXICOKINETICS; URINE LEVEL;

ACROLEIN; ADMINISTRATION, INHALATION; ADULT; AGED; BENZENE; BIOLOGICAL MARKERS; CARBON MONOXIDE; CARBOXYHEMOGLOBIN; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; INHALATION EXPOSURE; MALE; MIDDLE AGED; NICOTINE; NITROSAMINES; PYRENES; SMOKE; SMOKING; TARS; TOBACCO SMOKE POLLUTION;

EID: 47949122669     PISSN: 02732300     EISSN: 10960295     Source Type: Journal    
DOI: 10.1016/j.yrtph.2008.04.014     Document Type: Article

References (38)

1. Baker R.R., and Dixon M. The retention of tobacco smoke constituents in the human respiratory tract. Inhalation Toxicology 18 (2006) 255-294
2. Benowitz N.L., Kuyt F., and Jacob III P. Circadian blood nicotine concentrations during cigarette smoking. Clinical Pharmacology & Therapeutics 32 (1982) 758-764
3. Benowitz N.L., Jacob III P., Kozlowski L.T., and Yu L. Influence of smoking fewer cigarettes on exposure to tar, nicotine, and carbon monoxide. The New England Journal of Medicine 315 (1986) 1310-1313
4. Benowitz N.L. Cotinine as a biomarker of environmental tobacco smoke exposure. Epidemiologic Reviews 18 (1996) 188-204
5. Benowitz N.L. Biomarkers of environmental tobacco smoke exposure. Environmental Health Perspectives 107 Suppl. 2 (1999) 349-355
6. Benowitz, N.L., 2001. Compensatory smoking of low-yield cigarettes. In: National Cancer Institute, Risks Associated with Smoking Cigarettes with Low Machine-Measured Yields of Tar and Nicotine. Smoking and Tobacco Control Monograph No. 13. Bethesda, MD. US Department of Health and Human Services, National Institutes of Health, National Cancer Institute. NIH Pub. No. 02-5074 (Chapter 3).
7. Benowitz N.L., Jacob III P., Bernert J.T., Wilson M., Wang L., Allen F., and Dempsey D. Carcinogen exposure during short-term switching from regular to light cigarettes. Cancer Epidemiology, Biomarkers & Prevention 14 6 (2005) 1376-1383
8. Bradford J.A., Harlan W.R., and Hanmer H.R. Nature of cigaret smoke-technic of experimental smoking. Industrial and Engineering Chemistry 28 7 (1936) 836-839
9. Counts M.E., Hsu F.S., and Tewes F.J. Development of a cigarette "market map" comparison methodology for evaluating new or non-conventional cigarettes. Regulatory Toxicology and Pharmacology 46 (2006) 225-242
10. Fagerström K.O. Measuring degree of physical dependence to tobacco smoking with reference to individualization of treatment. Addictive Behaviors 3 (1978) 235-241
11. Federal Trade Commission, 1967. Statement of Considerations. Press release. August 1, 1967, pp. 2.
12. Feng S., Roethig H.J., Liang Q., Kinser R., Jin Y., Scherer G., Urban M., Engl J., and Riedel K. Evaluation of urinary 1-hydroxypyrene, S-phenylmercapturic acid, trans,trans-muconic acid, 3-methyladenine, 3-ethyladenine, 8-hydroxy-2′-deoxyguanosine and thioethers as biomarkers of exposure to cigarette smoke. Biomarkers 11 (2006) 28-52
13. Feng S., Plunkett S.E., Lam K., Kapur S., Muhammad R., Jin Y., Zimmermann M., Mendes P., Kinser R., and Roethig H.J. A new method for estimating the retention of selected smoke constituents in the respiratory tract of smokers during cigarette smoking. Inhalation Toxicology 19 (2007) 169-179
14. Feng S., Kapur S., Sarkar M., Muhammad R., Mendes P., and Roethig H.J. Respiratory retention of nicotine and urinary excretion of nicotine and its five major metabolites in adult male smokers. Toxicology Letters 173 (2007) 101-106
15. Frost-Pineda, K., Zedler, B.K., Oliveri, D., Liang, Q., Feng, S., Roethig, H.J., 2008. 12-week clinical exposure evaluation of a third-generation electrically heated cigarette smoking system (EHCSS) in adult smokers. Regulatory Toxicology and Pharmacology. doi:10.1016/j.yrtph.2008.05.015.
16. Green C.R., and Rodgman A. The tobacco chemists' research conference: a half century forum for advances in analytical methodology of tobacco and its products. Recent Advances in Tobacco Science 22 (1996) 131-304
17. Gori G.B., and Lynch C.J. Analytical cigarette yields as predictors of smoke bioavailability. Regulatory Toxicology and Pharmacology 5 (1985) 314-326
18. Hatsukami D.K., Benowitz N.L., Rennard S.I., Oncken C., and Hecht S.S. Biomarkers to assess the utility of potential reduced exposure tobacco products. Nicotine & Tobacco Research 8 (2006) 600-622
19. Hecht S.S., Carmella S.G., Chen M., Dor Koch J.F., Miller A.T., Murphy S.E., Jensen J.A., Zimmerman C.L., and Hatsukami D.K. Quantitation of urinary metabolites of a tobacco-specific lung carcinogen after smoking cessation. Cancer Research 59 (1999) 590-596
20. Hecht S.S. Human urinary carcinogen metabolites: biomarkers for investigating tobacco and cancer. Carcinogenesis 23 (2002) 907-922
21. Hecht S.S., Murphy S.E., Carmella S.G., Li S., Jensen J., Le C., Joseph A.M., and Hatsukami D.K. Similar uptake of lung carcinogens by smokers of regular, light, and ultralight cigarettes. Cancer Epidemiology Biomarkers & Prevention 14 (2005) 693-698
22. Hee J., Callais F., Momas I., Laurent A.M., Min S., Molinier P., Chastagnier M., Claude J.R., and Festy B. Smokers' behaviour and exposure according to cigarette yield and smoking experience. Pharmacology Biochemistry and Behavior 52 (1995) 195-203
23. Institute of Medicine, 2001. Clearing the Smoke: Assessing the Science Base for Tobacco Harm Reduction. Washington, DC, National Academy Press.
24. Jarvis M.J., Boreham R., Primatesta P., Feyerabend C., and Bryant A. Nicotine yield from machine-smoked cigarettes and nicotine intakes in smokers: evidence from a representative population survey. Journal of the National Cancer Institute 93 (2001) 134-138
25. Lynch C.J., and Benowitz N.L. Spontaneous cigarette brand switching: consequences for nicotine and carbon monoxide exposure. American Journal of Public Health 78 (1987) 1191-1194
26. Mascher D.G., Mascher H.J., Scherer G., and Schmid E.R. High-performance liquid chromatographic-tandem mass spectrometric determination of 3-hydroxypropylmercapturic acid in human urine. Journal of Chromatography B: Biomedical Science and Application 750 (2001) 163-169
27. Moldoveanu S.C., and StCharles F.K. Differences in the chemical composition of the particulate phase of inhaled and exhaled cigarette mainstream smoke. Beitraege zur Tabakforschung International 22 (2007) 290-302
28. Pillsbury H.G., Bright C.C., O'Connor K.J., and Irish F.W. Tar and nicotine in cigarette smoke. Journal of the Association of Official Analytical Chemists 52 (1969) 458-462
29. Qu Q., Melikian A.A., Li G., Shore R., Chen L., Cohen B., Yin S., Kagan M.R., Li H., Meng M., Jin X., Winnik W., Li Y., Mu R., and Li K. Validation of biomarkers in humans exposed to benzene: urine metabolites. American Journal Of Industrial Medicine 37 (2000) 522-531
30. Roethig H.J., Kinser R.D., Lau R.W., Walk R.A., and Wang N. Short-term exposure evaluation of adult smokers switching from conventional to first-generation electrically heated cigarettes during controlled smoking. The Journal of Clinical Pharmacology 45 (2005) 133-145
31. Roethig H.J., Zedler B.K., Kinser R.D., Feng S., Nelson B.L., and Liang Q. Short-term clinical exposure evaluation of second-generation electrically heated cigarette smoking system. The Journal of Clinical Pharmacology 47 (2007) 518-530
32. Russell M.A., Wilson C., Patel U.A., Cole P.V., and Feyerabend C. Comparison of effect on tobacco consumption and carbon monoxide absorption of changing to high and low nicotine cigarettes. British Medical Journal 4 (1973) 512-516
33. Sarkar M.A., Liang Q., Feng S., Kinser R., and Roethig H.J. Evaluation of a clinical model to determine exposure from conventional cigarettes in adult smokers. Journal of Clinical Pharmacology 44 (2004) 1213
34. Scherer G. Smoking behavior and compensation: a review of the literature. Psychopharmacology 145 (1999) 1-20
35. Scherer G., Frank S., Riedel K., Meger-Kossien I., and Renner T. Biomonitoring of exposure to polycyclic aromatic hydrocarbons of non-occupationally exposed persons. Cancer Epidemiology Biomarkers & Prevention 9 (2000) 373-380
36. US DHSS FDA. Guidance for Industry Bioanalytical Method Validation. Available from: http://www.fda.gov/cder/guidance/4252fnl.pdf. 2001, Accessed July 12, 2006.
37. ® System (1999), SAS Institute Inc., Cary, NC pp. 29-30
38. World Medical Association. World Medical Association 2000 Declaration of Helsinki Ethical Principles for Medical Research Involving Human Subjects. Edinburgh, Scotland: 52nd WMA General Assembly, 2000.